Kunte, S., Braman, N., Bera, K., Leo, P., Abraham, J., Montero, A., & Madabhushi, A.(2020).Radiomics risk score (RRS) on CT to predict survival and response to CDK 4/6 inhibitors in hormone receptor (HR) positive metastatic breast cancer (MBC)..Journal of Clinical Oncology,38(15_suppl),e13041-e13041.
Vulchi, M., El Adoui, M., Braman, N., Turk, P., Etesami, M., Drisis, S., Plecha, D., Benjelloun, M., Madabhushi, A., & Abraham, J.(2019).Development and external validation of a deep learning model for predicting response to HER2-targeted neoadjuvant therapy from pretreatment breast MRI..Journal of Clinical Oncology,37(15_suppl),593-593.
Braman, N., Prasanna, P., Whitney, J., Singh, S., Beig, N., Etesami, M., Bates, D., Gallagher, K., Bloch, B., Vulchi, M., Turk, P., Bera, K., Abraham, J., Sikov, W., Somlo, G., Harris, L., Gilmore, H., Plecha, D., Varadan, V., & Madabhushi, A.(2019).Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2) �Positive Breast Cancer.JAMA Network Open,2(4),e192561.
Braman, N., Ravichandran, K., Janowczyk, A., Abraham, J., & Madabhushi, A.(2018).Predicting neo-adjuvant chemotherapy response from pre-treatment breast MRI using machine learning and HER2 status..Journal of Clinical Oncology,36(15_suppl),582-582.
